Pharmaceuticals & Life Sciences
Assurance, inspection, and certification services for pharmaceuticals, biotechnology, and life sciences industries worldwide.
Pharmaceuticals & Life Sciences
In the tightly regulated world of pharmaceuticals and life sciences, precision, safety, and compliance are paramount.
BQCIS delivers analytical, microbiological, and bio-compatibility testing combined with full GxP auditing and certification to ensure the highest standards of product integrity and patient safety.
From drug development to post-market surveillance, our laboratories and technical teams help pharmaceutical, biotechnology, and healthcare organizations maintain quality systems that meet global regulatory expectations.
Assuring Quality and Safety Across the Drug Lifecycle
BQCIS supports pharmaceutical manufacturers, contract research organizations, and life-science innovators with reliable data and regulatory compliance across discovery, development, manufacturing, and distribution.
Our global network of GMP and ISO 17025–accredited laboratories provides analytical chemistry, microbiological, stability, and bio-compatibility testing alongside validation, auditing, and certification programs.
From pre-clinical testing and raw-material qualification to batch release and pharmacovigilance, BQCIS ensures data integrity, traceability, and confidence for regulators and patients alike.
Key Benefits
Regulatory Confidence
GMP-compliant data, validated methods, and certified audit systems support seamless global submissions.
Accelerated Development
Integrated analytical and microbiological testing shortens R&D timelines and facilitates faster approvals.
Assured Patient Safety
Independent verification of sterility, potency, and stability ensures consistent therapeutic performance.
End-to-End Transparency
Digital reporting and blockchain-secured certificates strengthen stakeholder trust across the pharma chain.
Success Story
Method Validation Restores Batch Release Certification
A generic-drug manufacturer failed regulatory inspection due to inconsistent assay validation and data-integrity gaps.
BQCIS re-validated the analytical method under ICH Q2 (R2), implemented ALCOA+ data controls, and retrained QC analysts.
The client regained GMP certification within six weeks, resumed export supply, and achieved 100 % inspection compliance.